Public advisory - Unauthorized injectable peptide drugs seized and sold by Canada Peptide may pose serious health risks Français
Issue: Health products – Unauthorized product; Product safety
What to do: Consult a healthcare professional if you have used an unauthorized injectable drug on the list below and have health concerns. Do not buy or use unauthorized drugs. Only buy prescription drugs from licensed pharmacies. Read product labels to confirm a product has been authorized for sale by Health Canada.
Affected products
Unauthorized injectable peptide drugs, including:
• AOD9604
• ARA 290
• Bremelanotide
• Bronchogen
• BPC-157
• CJC-1295
• Cortagen
• DSIP
• Epitalon
• GHK, GHK-Cu
• GHRP 2
• GHRP 6
• GLP-1 (7-37)
• Gonadorelin
• Hexarelin
• HGH, HGH Fragment
• Humanine
• Ipamoreline
• Kisspeptin
• KK-23
• Livagen
• LL-37
• Melanotan 1
• Melanotan II
• NR-7
• Ovagen
• Pal-GHK
• Pinealon
• PNC-27
• Prostamax
• QS-13
• Retatrutide
• Selank
• Semax
• Sermorelin
• SS-31
• Tesamorelin
• Thymosin alpha
• Thymosin-β4 (TB4 or TB-500)
• Tirzepatide
• Vilon
• VIP
Issue
Health Canada is warning the public of seized unauthorized injectable peptide drugs from Canada Peptide. The products were being sold via the company's website. Peptide drugs affect the body's functions and are often used for bodybuilding, anti-aging, or enhancing athletic performance. Injectable peptides are regulated as prescription drugs in Canada.
Health Canada has not authorized any of the products that were seized or sold on the company's website, which means that they have not been assessed for safety, efficacy, and quality. Selling unauthorized drugs is illegal in Canada.
Prescription drugs should only be used under the care of a healthcare professional because they are used to treat specific conditions and may cause serious side effects. Unauthorized injectable drugs may:
Cause infectionallergic reactions, and other poor outcomes.
Interact with other medications an individual might be taking.
Contain high-risk ingredients, additives, or contaminants that may or may not be listed on the label.
Not have been manufactured or stored safely.
Should additional safety concerns be identified, Health Canada will take appropriate action to protect public health and safety, including communicating updates, if needed.
What you should do
Consult a health care professional (physician, nurse practitioner, pharmacist) if you have used an unauthorized injectable drug and have health concerns.
Follow municipal or regional guidelines on how to dispose of chemicals and other hazardous waste or return the product to your local pharmacy for proper disposal.
Only buy prescription drugs from licensed pharmacies. Be aware of the risks of buying health products online.
Do not buy or use unauthorized drugs. You can read product labels to confirm the product has been authorized for sale by Health Canada. Authorized health products have an eight-digit Drug Identification Number (DIN), Natural Product Number (NPN) or Homeopathic Drug Number (DIN-HM). You can also check whether products have been authorized for sale by searching Health Canada's Drug Product Database and Licensed Natural Health Product Database.
Report any health product-related side effects or complaints to Health Canada.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBC
16 hours ago
- CBC
Health Canada issues recall for BChic, Chicure baby nest beds over safety risks
Social Sharing Health Canada issued a recall notice on Friday for BChic and Chicure model baby nest beds over various safety risks. The department said the "eleven" brand baby co-sleeping bed and luggage middle beds don't meet regulations and have the potential for "fall, strangulation and entrapment hazards," but it notes there have no been no reported incidents or injuries in Canada so far. "Consumers should immediately stop using the recalled products and safely dispose of the items in such a way that they cannot be used again," Health Canada said. "Health Canada reminds parents and caregivers that the safest place for a baby to sleep is on their back on a firm, flat surface intended for sleep."
CTV News
18 hours ago
- CTV News
‘Stop using immediately': Health Canada issues recall for baby nests
Health Canada issued a recall for BChic and Chicure model baby nests sold under the 'eleven' brand by CHIC BABY, warning the products pose a risk of fall, strangulation and entrapment. The recalled products include a head pillow and were sold in a variety of printed fabrics. Each nest has a tag with the brand name 'eleven.' The Chicure model also folds into a portable handbag with a handle. CHIC BABY reported that 3,007 units of the affected products were sold in Canada between February 2020 and July 2025. As of July 18, 2025, the company has not received any reports of injuries or incidents related to the use of these products in Canada. Health Canada is reminding parents and caregivers that the safest place for a baby to sleep is on their back, on a firm, flat surface intended for sleep. More information is available in the department's safe sleep guidelines for infants. Consumers are advised to immediately stop using the recalled baby nests and to dispose of them safely to ensure they cannot be reused. For more information, consumers can contact CHIC BABY by email at info@ or visit the company's website. Health Canada also encourages consumers to report any health or safety incidents involving this or other consumer products by filling out the Consumer Product Incident Report Form.
Winnipeg Free Press
2 days ago
- Winnipeg Free Press
Pharmacists reject tobacco giant's argument for more retail access to nicotine pouches
Canada's largest tobacco company is ratcheting up efforts to rescind a federal government order last year requiring that nicotine pouches be sold behind the counter at pharmacies. Imperial Tobacco's public relations campaign says that the ministerial order has made its Zonnic nicotine-replacement therapy pouches more difficult for smokers to access. Pharmacists — 'front-line health professionals who are already time-squeezed and over-burdened' — are 'increasingly disgruntled by the new demands of this order,' it said. SUBMITTED An advertisement in a convenience store that sells Zonnic, a nicotine replacement product to help adults quit smoking that is not authorized to be sold to anyone under the age of 18. Users place the pouches between their upper lip and gum for up to 60 minutes, releasing nicotine that temporarily curbs cravings and nicotine withdrawal symptoms, Imperial Tobacco says on its Zonnic website. The association representing Manitoba pharmacists called that 'very, very strange.' 'There's no pharmacist being disgruntled or frustrated about the need to have people access these products in pharmacies,' said Britt Kural, pharmacy practice adviser with Pharmacists Manitoba. 'This is what we do — we do it really well.' She said pharmacists are among the most accessible health-care providers and able to help people find the right product to help them stop smoking. 'Pharmacists are experts in smoking cessation and we want to help people find the best options to help them in that journey,' Kural said Friday. The pharmacy 'is exactly the right spot' for nicotine pouches that Imperial Tobacco and the government have classified as nicotine replacement therapy (NRT). 'We appreciate being able to have them available to consider for people when they want to stop smoking,' she said. Not every pharmacist appreciates being 'the gatekeeper and policing an NRT product that has been approved by Health Canada,' said Imperial Tobacco's vice-president of corporate and regulatory affairs. Eric Gagnon said the company has heard concerns raised by pharmacy groups about it increasing their workload. 'I wouldn't say that everybody's on the same page,' he said from Montreal. 'The Neighbourhood Pharma Association has raised concern about moving (nicotine replacement therapies) behind the pharmacy counter,' said Gagnon. That could place an 'additional burden on pharmacy professionals,' he said. 'We hosted an event in Western Canada with pharmacists a few months ago, and they also raised some concerns.' When the federal order was issued last August, Zonnic could no longer be sold where smokers regularly purchase cigarettes, and the flavours were restricted to mint and menthol. At the time, Gagnon accused the federal health minister of 'singling out' Imperial Tobacco, while giving pharmaceutical companies a pass. 'All smoking cessation products should be regulated in the same way,' Gagnon said in an Aug. 22, 2024 press release. 'This is not how good public health policy is made.' When Zonnic tins — containing 24 pouches — were sold in convenience stores, there was an accelerated decline in cigarette sales, said Gagnon, adding that they've helped 'many thousands' quit smoking. Nearly a year later, moving nicotine pouches behind the counter hasn't helped those trying to quit smoking, or Canada in meeting its stated goal of attaining a smoking rate of below five per cent by 2035, he said. 'We're concerned that either people will start smoking again or, as we have seen, people will start buying illegal nicotine products which often contain a lot more than the four milligrams that has been approved by Health Canada.' He said specialty and online shops are illegally selling products that contain six, nine or even 15 milligrams of nicotine. The push to get pouches sold over the counter alongside cigarettes comes after the settlement of a class-action lawsuit by provinces including Manitoba. Big Tobacco companies — including Imperial — are to cough up billions in after-tax profits solely from tobacco sales over the next 20 years. 'They need to get as many people addicted to alternative products — which includes pouches — as possible, for survival,' said the head of the Manitoba Tobacco Reduction Alliance. Cynthia Carr predicted after the tobacco settlement was announced in March that the companies would push for easier access to highly addictive nicotine pouches to grow their customer base. 'Not only are they handing over $6 billion or so, cash in hand, to start, they then have to start providing up to 85 per cent of their after-tax profits from tobacco. So if they only have a tiny portion left, of course they're going to sell every other product they can,' said Carr, a Winnipeg epidemiologist. The federal government cracked down on the colourful packaging and flavours of nicotine pouches after studies showed youths were attracted and increasingly using them, Carr said Friday. Wednesdays What's next in arts, life and pop culture. 'The company was marketing this to that younger audience, making them fun, fancy flavours — cool designs that were really meant to appeal to a younger population,' said Kural. 'There can be some serious health consequences to underage individuals using these types of nicotine products or any nicotine product,' the pharmacist said. 'That younger population may not understand the consequences that nicotine can have on their overall health and especially in the growth stage of their health.' Kural said she doesn't think that pharmacists — or any health-care practitioner — would support returning nicotine pouches to over-the-counter sales. 'We're trying to prevent this from falling into the hands of people who shouldn't be using it,' she said. Carol SandersLegislature reporter Carol Sanders is a reporter at the Free Press legislature bureau. The former general assignment reporter and copy editor joined the paper in 1997. Read more about Carol. Every piece of reporting Carol produces is reviewed by an editing team before it is posted online or published in print — part of the Free Press's tradition, since 1872, of producing reliable independent journalism. Read more about Free Press's history and mandate, and learn how our newsroom operates. Our newsroom depends on a growing audience of readers to power our journalism. If you are not a paid reader, please consider becoming a subscriber. Our newsroom depends on its audience of readers to power our journalism. Thank you for your support.
